ClinicalTrials.govpublic full text
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
acute myeloid leukemia, myelodysplastic syndromes, high risk myelodysplastic syndrome (mds), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980702
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.